PBAC's latest decision on Continued dispensing: Noted (2021). Considered for Continued Dispensing arrangements for chronic disease medicines and HIV antiretrovirals when immediate supply is needed and prescription cannot be obtained.
PBAC outcome
Noted
Not applicable
ICER (AUD/QALY)
Not modelled
no economic evaluation
Submissions
1
first 2021
Submissions
1
2021 → 2021
Eligible population
Patients requiring chronic disease medicines (asthma, lung disease, diabetes, heart disease) or HIV antiretrovirals when immediate supply is needed and it is not practicable to obtain a prescription.
Therapy area
Other
Line of therapy
Not applicable
Evidence base
Other
Economic model
Not modelled
Eligible patients/year
360,000
ICER note
Not applicable — this is a policy/arrangements item, not a drug submission with economic evaluation.